Skip to content

Alto Neuroscience ANRO FX Effect on Cash

FX Effect on Cash at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$130K-103%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$25K+600%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$126K+154%
Medtronic logo
MedtronicMDT
$33M-88.3%
Arrowhead Research logo
Arrowhead ResearchARWR
$997K+348%
IAR
Integra LifeSciencesIART
-$1.49M-133%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's FX effect on cash?
Alto Neuroscience (ANRO) reported FX effect on cash of -$16K in Q1 2026.
How has Alto Neuroscience's FX effect on cash changed year-over-year?
Alto Neuroscience's FX effect on cash increased by 27.3% year-over-year, from -$22K to -$16K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.